Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RBR-7nq5sqnNot yet recruiting
Single-blind, single-arm trial in Eczema and Papulosquamous dermatosis, sponsored by Universidade São Francisco. Primary endpoints: Photoirritant potential of KY BIO and Photosensitization potential of KY BIO. Planned start Jan 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on RBR-7nq5sqn.